Locana

Jim Burns, Ph.D., CEO
San Diego, CA
(Private)
Locana is creating a new class of gene therapies by treating  disease causing mRNA involved in disease. The Locana platform enables a portfolio of gene therapy systems to modify RNA across multiple mechanisms of action with the goal of creating precise and durable genetic medicines for the benefit of patients without DNA modification.
www.locanabio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions